UK industry welcomes Budget boosts for life sciences

New R&D tax incentives for SMEs, funding for the medicines regulator and ‘hidden benefits’ delight the UK bioindustry.

Edwards Lifesciences revives Fintiv challenge

The medtech company and its fellow tech giant plaintiffs can now challenge the controversial rule.

Abbott fails to stay claims in baby formula milk dispute

“Customer suit exception” is rejected by district judge leaving the suit involving Chr. Hansen and Glycosyn ongoing.

The Dutch non-profit taking on AbbVie for ‘overpricing' Humira by $1.3bn

The Dutch non-profit taking on AbbVie for ‘overpricing' Humira by $1.3bn

The Pharmaceutical Accountability Foundation has accused the pharma giant of excessively pricing its blockbuster drug, and believes it could influence the regulation of pricing and patent policy for global medicines in the process.

More features

Latest news

UK industry welcomes Budget boosts for life sciences

16-03-2023

New R&D tax incentive announced for SMEs in UK Budget | Funding for medicines regulator aims to open up drug approvals | ‘Hidden benefits’ in Budget for industry | Reaction from Bioindustry Association, Potter Clarkson, Mischon de Reya, Marks & Clerk, Taylor Wessing.

Novartis loses EU court bid to revoke inhaler trademark

16-03-2023

Edwards Lifesciences revives Fintiv challenge

14-03-2023

Abbott fails to stay claims in baby formula milk dispute

14-03-2023

Don’t distort enablement law, Amgen tells SCOTUS

09-03-2023

Gilead defeats immunity bid in hepatitis C patent case

07-03-2023

More news

Regions

Sectors

LSIPR